Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress

PGPIPN is a therapeutic hexapeptide derived from bovine β-casein. Here we investigated the role and mechanism of this peptide on alcoholic fatty liver disease (AFLD). We took human hepatic cell line LO2 and hepatocellular carcinoma cell line HepG2 to establish the models of steatosis hepatocyte indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Nan, Liu, Chen, Yang, Haoran, Shi, Wanrong, Wang, Shenyi, Zhou, Yan, Wei, Cai, Gu, Fang, Qin, Yide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675695/
https://www.ncbi.nlm.nih.gov/pubmed/29152143
http://dx.doi.org/10.18632/oncotarget.21404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675695/
https://www.ncbi.nlm.nih.gov/pubmed/29152143
http://dx.doi.org/10.18632/oncotarget.21404

Ejemplares similares